Self	B:C0033684
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	B:C0005479
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	B:C0178719
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	B:C0003241
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	B:C0003241
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	B:C0178719
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	B:C1611640
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	B:C0003241
antibodies	I:C0003241
inside	O
cells	O
.	O

Self	O
-	I:C0033684
assembled	I:C0033684
protein	I:C0033684
nanocarrier	O
for	O
intracellular	O
delivery	O
of	O
antibody	O
Despite	O
the	O
great	O
potential	O
of	O
antibodies	O
as	O
intracellular	O
therapeutics	O
,	O
there	O
is	O
a	O
significant	O
,	O
unmet	O
challenge	O
in	O
delivering	O
sufficient	O
amounts	O
of	O
folded	O
antibodies	I:C0003241
inside	O
cells	B:C0007634
.	O

We	O
describe	O
an	O
all	B:C0033684
-	I:C0033684
protein	I:C0033684
self	O
-	I:C0005479
assembled	I:C0005479
nanocarrier	I:C0005479
capable	O
of	O
delivering	O
functional	O
antibodies	O
to	O
the	O
cytosol	O
.	O

We	O
describe	O
an	O
all	O
-	I:C0033684
protein	I:C0033684
self	B:C0005479
-	I:C0005479
assembled	I:C0005479
nanocarrier	I:C0005479
capable	O
of	O
delivering	O
functional	O
antibodies	O
to	O
the	O
cytosol	O
.	O

We	O
describe	O
an	O
all	O
-	I:C0033684
protein	I:C0033684
self	O
-	I:C0005479
assembled	I:C0005479
nanocarrier	I:C0005479
capable	O
of	O
delivering	O
functional	O
antibodies	B:C0003241
to	O
the	O
cytosol	O
.	O

We	O
describe	O
an	O
all	O
-	I:C0033684
protein	I:C0033684
self	O
-	I:C0005479
assembled	I:C0005479
nanocarrier	I:C0005479
capable	O
of	O
delivering	O
functional	O
antibodies	O
to	O
the	O
cytosol	B:C1383501
.	O

By	O
combining	O
an	O
α-helical	B:C0030956
peptide	I:C0030956
that	O
self	O
-	O
assembles	O
into	O
a	O
hexameric	O
coiled	I:C1510464
-	I:C1510464
coil	I:C1510464
bundle	I:C1510464
and	O
an	O
Fc-	O
binding	I:C0038164
Protein	I:C0038164
A	I:C0038164
fragment	I:C0038164
,	O
we	O
generated	O
the	O
Hex	O
nanocarrier	I:C0005479
that	O
is	O
efficiently	O
internalized	O
by	O
cells	O
without	O
cytotoxicity	O
.	O

By	O
combining	O
an	O
α-helical	O
peptide	I:C0030956
that	O
self	O
-	O
assembles	O
into	O
a	O
hexameric	B:C1510464
coiled	I:C1510464
-	I:C1510464
coil	I:C1510464
bundle	I:C1510464
and	O
an	O
Fc-	O
binding	I:C0038164
Protein	I:C0038164
A	I:C0038164
fragment	I:C0038164
,	O
we	O
generated	O
the	O
Hex	O
nanocarrier	I:C0005479
that	O
is	O
efficiently	O
internalized	O
by	O
cells	O
without	O
cytotoxicity	O
.	O

By	O
combining	O
an	O
α-helical	O
peptide	I:C0030956
that	O
self	O
-	O
assembles	O
into	O
a	O
hexameric	O
coiled	I:C1510464
-	I:C1510464
coil	I:C1510464
bundle	I:C1510464
and	O
an	O
Fc-	B:C0038164
binding	I:C0038164
Protein	I:C0038164
A	I:C0038164
fragment	I:C0038164
,	O
we	O
generated	O
the	O
Hex	O
nanocarrier	I:C0005479
that	O
is	O
efficiently	O
internalized	O
by	O
cells	O
without	O
cytotoxicity	O
.	O

By	O
combining	O
an	O
α-helical	O
peptide	I:C0030956
that	O
self	O
-	O
assembles	O
into	O
a	O
hexameric	O
coiled	I:C1510464
-	I:C1510464
coil	I:C1510464
bundle	I:C1510464
and	O
an	O
Fc-	O
binding	I:C0038164
Protein	I:C0038164
A	I:C0038164
fragment	I:C0038164
,	O
we	O
generated	O
the	O
Hex	B:C0005479
nanocarrier	I:C0005479
that	O
is	O
efficiently	O
internalized	O
by	O
cells	O
without	O
cytotoxicity	O
.	O

By	O
combining	O
an	O
α-helical	O
peptide	I:C0030956
that	O
self	O
-	O
assembles	O
into	O
a	O
hexameric	O
coiled	I:C1510464
-	I:C1510464
coil	I:C1510464
bundle	I:C1510464
and	O
an	O
Fc-	O
binding	I:C0038164
Protein	I:C0038164
A	I:C0038164
fragment	I:C0038164
,	O
we	O
generated	O
the	O
Hex	O
nanocarrier	I:C0005479
that	O
is	O
efficiently	O
internalized	O
by	O
cells	B:C0007634
without	O
cytotoxicity	O
.	O

By	O
combining	O
an	O
α-helical	O
peptide	I:C0030956
that	O
self	O
-	O
assembles	O
into	O
a	O
hexameric	O
coiled	I:C1510464
-	I:C1510464
coil	I:C1510464
bundle	I:C1510464
and	O
an	O
Fc-	O
binding	I:C0038164
Protein	I:C0038164
A	I:C0038164
fragment	I:C0038164
,	O
we	O
generated	O
the	O
Hex	O
nanocarrier	I:C0005479
that	O
is	O
efficiently	O
internalized	O
by	O
cells	O
without	O
cytotoxicity	B:C0596402
.	O

Localization	O
of	O
multiple	O
Fc-	B:C1514535
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	O
core	I:C0444669
allowed	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
tightly	O
bind	O
antibody	O
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	O
's	O
originating	O
species	O
.	O

Localization	O
of	O
multiple	O
Fc-	O
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	B:C0444669
core	I:C0444669
allowed	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
tightly	O
bind	O
antibody	O
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	O
's	O
originating	O
species	O
.	O

Localization	O
of	O
multiple	O
Fc-	O
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	O
core	I:C0444669
allowed	O
the	O
Hex	B:C0005479
nanocarrier	I:C0005479
to	O
tightly	O
bind	O
antibody	O
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	O
's	O
originating	O
species	O
.	O

Localization	O
of	O
multiple	O
Fc-	O
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	O
core	I:C0444669
allowed	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
tightly	O
bind	B:C1167622
antibody	O
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	O
's	O
originating	O
species	O
.	O

Localization	O
of	O
multiple	O
Fc-	O
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	O
core	I:C0444669
allowed	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
tightly	O
bind	O
antibody	B:C0003241
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	O
's	O
originating	O
species	O
.	O

Localization	O
of	O
multiple	O
Fc-	O
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	O
core	I:C0444669
allowed	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
tightly	O
bind	O
antibody	O
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	B:C0003241
's	O
originating	O
species	O
.	O

Localization	O
of	O
multiple	O
Fc-	O
binding	I:C1514535
domains	I:C1514535
on	O
the	O
hexameric	O
core	I:C0444669
allowed	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
tightly	O
bind	O
antibody	O
with	O
sub-nanomolar	O
affinity	O
regardless	O
of	O
pH	O
and	O
the	O
antibody	O
's	O
originating	O
species	B:C1705920
.	O

The	O
size	B:C0456389
of	O
the	O
Hex	O
nanocarrier	I:C0005479
ranges	O
from	O
25	O
to	O
35nm	O
depending	O
on	O
the	O
antibody	O
loading	O
ratio	O
.	O

The	O
size	O
of	O
the	O
Hex	B:C0005479
nanocarrier	I:C0005479
ranges	O
from	O
25	O
to	O
35nm	O
depending	O
on	O
the	O
antibody	O
loading	O
ratio	O
.	O

The	O
size	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
ranges	O
from	O
25	O
to	O
35nm	O
depending	O
on	O
the	O
antibody	B:C0003241
loading	O
ratio	O
.	O

We	O
demonstrated	O
the	O
capacity	O
of	O
the	O
Hex	B:C0005479
nanocarrier	I:C0005479
to	O
deliver	O
functional	O
antibodies	O
to	O
the	O
cytosol	O
by	O
employing	O
anti-β-	O
tubulin	I:C1276241
or	O
anti-nuclear	O
pore	I:C0003241
complex	I:C0003241
antibody	I:C0003241
as	O
cargo	O
.	O

We	O
demonstrated	O
the	O
capacity	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
deliver	O
functional	O
antibodies	B:C0003241
to	O
the	O
cytosol	O
by	O
employing	O
anti-β-	O
tubulin	I:C1276241
or	O
anti-nuclear	O
pore	I:C0003241
complex	I:C0003241
antibody	I:C0003241
as	O
cargo	O
.	O

We	O
demonstrated	O
the	O
capacity	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
deliver	O
functional	O
antibodies	O
to	O
the	O
cytosol	B:C1383501
by	O
employing	O
anti-β-	O
tubulin	I:C1276241
or	O
anti-nuclear	O
pore	I:C0003241
complex	I:C0003241
antibody	I:C0003241
as	O
cargo	O
.	O

We	O
demonstrated	O
the	O
capacity	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
deliver	O
functional	O
antibodies	O
to	O
the	O
cytosol	O
by	O
employing	O
anti-β-	B:C1276241
tubulin	I:C1276241
or	O
anti-nuclear	O
pore	I:C0003241
complex	I:C0003241
antibody	I:C0003241
as	O
cargo	O
.	O

We	O
demonstrated	O
the	O
capacity	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
to	O
deliver	O
functional	O
antibodies	O
to	O
the	O
cytosol	O
by	O
employing	O
anti-β-	O
tubulin	I:C1276241
or	O
anti-nuclear	B:C0003241
pore	I:C0003241
complex	I:C0003241
antibody	I:C0003241
as	O
cargo	O
.	O

The	O
design	O
of	O
the	O
Hex	B:C0005479
nanocarrier	I:C0005479
is	O
modular	O
,	O
which	O
enables	O
functionalization	O
beyond	O
Fc-binding	O
.	O

The	O
design	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
is	O
modular	O
,	O
which	O
enables	O
functionalization	O
beyond	O
Fc-binding	B:C0033618
.	O

We	O
exploited	O
this	O
feature	O
to	O
improve	O
the	O
cytosolic	B:C1383501
delivery	O
efficiency	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
by	O
addition	O
of	O
an	O
endosomolytic	O
motif	O
to	O
the	O
core	O
.	O

We	O
exploited	O
this	O
feature	O
to	O
improve	O
the	O
cytosolic	O
delivery	O
efficiency	O
of	O
the	O
Hex	B:C0005479
nanocarrier	I:C0005479
by	O
addition	O
of	O
an	O
endosomolytic	O
motif	O
to	O
the	O
core	O
.	O

We	O
exploited	O
this	O
feature	O
to	O
improve	O
the	O
cytosolic	O
delivery	O
efficiency	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
by	O
addition	O
of	O
an	O
endosomolytic	B:C0034850
motif	O
to	O
the	O
core	O
.	O

We	O
exploited	O
this	O
feature	O
to	O
improve	O
the	O
cytosolic	O
delivery	O
efficiency	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
by	O
addition	O
of	O
an	O
endosomolytic	O
motif	B:C1514562
to	O
the	O
core	O
.	O

We	O
exploited	O
this	O
feature	O
to	O
improve	O
the	O
cytosolic	O
delivery	O
efficiency	O
of	O
the	O
Hex	O
nanocarrier	I:C0005479
by	O
addition	O
of	O
an	O
endosomolytic	O
motif	O
to	O
the	O
core	B:C0444669
.	O

The	O
modified	O
Hex	B:C0005479
nanocarrier	I:C0005479
exhibited	O
similar	O
antibody	O
-	O
binding	O
behavior	O
,	O
but	O
delivered	O
more	O
antibodies	O
to	O
their	O
cytosolic	O
targets	O
at	O
a	O
faster	O
rate	O
.	O

The	O
modified	O
Hex	O
nanocarrier	I:C0005479
exhibited	O
similar	O
antibody	B:C0003241
-	O
binding	O
behavior	O
,	O
but	O
delivered	O
more	O
antibodies	O
to	O
their	O
cytosolic	O
targets	O
at	O
a	O
faster	O
rate	O
.	O

The	O
modified	O
Hex	O
nanocarrier	I:C0005479
exhibited	O
similar	O
antibody	O
-	O
binding	O
behavior	O
,	O
but	O
delivered	O
more	O
antibodies	B:C0003241
to	O
their	O
cytosolic	O
targets	O
at	O
a	O
faster	O
rate	O
.	O

The	O
modified	O
Hex	O
nanocarrier	I:C0005479
exhibited	O
similar	O
antibody	O
-	O
binding	O
behavior	O
,	O
but	O
delivered	O
more	O
antibodies	O
to	O
their	O
cytosolic	B:C1383501
targets	O
at	O
a	O
faster	O
rate	O
.	O

This	O
work	O
demonstrates	O
an	O
efficient	O
intracellular	B:C0178719
antibody	O
delivery	O
platform	O
with	O
significant	O
advantages	O
over	O
existing	O
approaches	O
as	O
it	O
does	O
not	O
require	O
modification	O
of	O
the	O
antibody	O
,	O
is	O
biodegradable	O
,	O
and	O
has	O
an	O
antibody	O
to	O
carrier	O
mass	O
ratio	O
of	O
13	O
,	O
which	O
is	O
greater	O
than	O
other	O
reported	O
antibody	O
carriers	O
.	O

This	O
work	O
demonstrates	O
an	O
efficient	O
intracellular	O
antibody	B:C0003241
delivery	O
platform	O
with	O
significant	O
advantages	O
over	O
existing	O
approaches	O
as	O
it	O
does	O
not	O
require	O
modification	O
of	O
the	O
antibody	O
,	O
is	O
biodegradable	O
,	O
and	O
has	O
an	O
antibody	O
to	O
carrier	O
mass	O
ratio	O
of	O
13	O
,	O
which	O
is	O
greater	O
than	O
other	O
reported	O
antibody	O
carriers	O
.	O

This	O
work	O
demonstrates	O
an	O
efficient	O
intracellular	O
antibody	O
delivery	O
platform	O
with	O
significant	O
advantages	O
over	O
existing	O
approaches	O
as	O
it	O
does	O
not	O
require	O
modification	B:C3840684
of	O
the	O
antibody	O
,	O
is	O
biodegradable	O
,	O
and	O
has	O
an	O
antibody	O
to	O
carrier	O
mass	O
ratio	O
of	O
13	O
,	O
which	O
is	O
greater	O
than	O
other	O
reported	O
antibody	O
carriers	O
.	O

This	O
work	O
demonstrates	O
an	O
efficient	O
intracellular	O
antibody	O
delivery	O
platform	O
with	O
significant	O
advantages	O
over	O
existing	O
approaches	O
as	O
it	O
does	O
not	O
require	O
modification	O
of	O
the	O
antibody	B:C0003241
,	O
is	O
biodegradable	O
,	O
and	O
has	O
an	O
antibody	O
to	O
carrier	O
mass	O
ratio	O
of	O
13	O
,	O
which	O
is	O
greater	O
than	O
other	O
reported	O
antibody	O
carriers	O
.	O

This	O
work	O
demonstrates	O
an	O
efficient	O
intracellular	O
antibody	O
delivery	O
platform	O
with	O
significant	O
advantages	O
over	O
existing	O
approaches	O
as	O
it	O
does	O
not	O
require	O
modification	O
of	O
the	O
antibody	O
,	O
is	O
biodegradable	O
,	O
and	O
has	O
an	O
antibody	O
to	O
carrier	O
mass	O
ratio	O
of	O
13	O
,	O
which	O
is	O
greater	O
than	O
other	O
reported	O
antibody	B:C0003241
carriers	O
.	O

This	O
work	O
demonstrates	O
an	O
efficient	O
intracellular	O
antibody	O
delivery	O
platform	O
with	O
significant	O
advantages	O
over	O
existing	O
approaches	O
as	O
it	O
does	O
not	O
require	O
modification	O
of	O
the	O
antibody	O
,	O
is	O
biodegradable	O
,	O
and	O
has	O
an	O
antibody	O
to	O
carrier	O
mass	O
ratio	O
of	O
13	O
,	O
which	O
is	O
greater	O
than	O
other	O
reported	O
antibody	O
carriers	B:C0013161
.	O

